TY - JOUR
T1 - Pediatric pancreas segmentation from MRI scans with deep learning
AU - Keles, Elif
AU - Yazol, Merve
AU - Durak, Gorkem
AU - Hong, Ziliang
AU - Aktas, Halil Ertugrul
AU - Zhang, Zheyuan
AU - Peng, Linkai
AU - Susladkar, Onkar
AU - Guzelyel, Necati
AU - Boyunaga, Oznur Leman
AU - Yazici, Cemal
AU - Lowe, Mark
AU - Uc, Aliye
AU - Bagci, Ulas
N1 - Publisher Copyright:
© 2025 IAP and EPC
PY - 2025/8
Y1 - 2025/8
N2 - Objective: Our study aimed to evaluate and validate PanSegNet, a deep learning (DL) algorithm for pediatric pancreas segmentation on MRI in children with acute pancreatitis (AP), chronic pancreatitis (CP), and healthy controls. Methods: With IRB approval, we retrospectively collected 84 MRI scans (1.5T/3T Siemens Aera/Verio) from children aged 2–19 years at Gazi University (2015–2024). The dataset includes healthy children as well as patients diagnosed with AP or CP based on clinical criteria. Pediatric and general radiologists manually segmented the pancreas, then confirmed by a senior pediatric radiologist. PanSegNet-generated segmentations were assessed using Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff distance (HD95). Cohen's kappa measured observer agreement. Results: Pancreas MRI T2W scans were obtained from 42 children with AP/CP (mean age: 11.73 ± 3.9 years) and 42 healthy children (mean age: 11.19 ± 4.88 years). PanSegNet achieved DSC scores of 88 % (controls), 81 % (AP), and 80 % (CP), with HD95 values of 3.98 mm (controls), 9.85 mm (AP), and 15.67 mm (CP). Inter-observer kappa was 0.86 (controls), 0.82 (pancreatitis), and intra-observer agreement reached 0.88 and 0.81. Strong agreement was observed between automated and manual volumes (R2 = 0.85 in controls, 0.77 in diseased), demonstrating clinical reliability. Conclusion: PanSegNet represents the first validated deep learning solution for pancreatic MRI segmentation, achieving expert-level performance across healthy and diseased states. This tool, algorithm, along with our annotated dataset, are freely available on GitHub and OSF, advancing accessible, radiation-free pediatric pancreatic imaging and fostering collaborative research in this underserved domain.
AB - Objective: Our study aimed to evaluate and validate PanSegNet, a deep learning (DL) algorithm for pediatric pancreas segmentation on MRI in children with acute pancreatitis (AP), chronic pancreatitis (CP), and healthy controls. Methods: With IRB approval, we retrospectively collected 84 MRI scans (1.5T/3T Siemens Aera/Verio) from children aged 2–19 years at Gazi University (2015–2024). The dataset includes healthy children as well as patients diagnosed with AP or CP based on clinical criteria. Pediatric and general radiologists manually segmented the pancreas, then confirmed by a senior pediatric radiologist. PanSegNet-generated segmentations were assessed using Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff distance (HD95). Cohen's kappa measured observer agreement. Results: Pancreas MRI T2W scans were obtained from 42 children with AP/CP (mean age: 11.73 ± 3.9 years) and 42 healthy children (mean age: 11.19 ± 4.88 years). PanSegNet achieved DSC scores of 88 % (controls), 81 % (AP), and 80 % (CP), with HD95 values of 3.98 mm (controls), 9.85 mm (AP), and 15.67 mm (CP). Inter-observer kappa was 0.86 (controls), 0.82 (pancreatitis), and intra-observer agreement reached 0.88 and 0.81. Strong agreement was observed between automated and manual volumes (R2 = 0.85 in controls, 0.77 in diseased), demonstrating clinical reliability. Conclusion: PanSegNet represents the first validated deep learning solution for pancreatic MRI segmentation, achieving expert-level performance across healthy and diseased states. This tool, algorithm, along with our annotated dataset, are freely available on GitHub and OSF, advancing accessible, radiation-free pediatric pancreatic imaging and fostering collaborative research in this underserved domain.
KW - Artificial intelligence
KW - Automatic segmentation
KW - Deep learning
KW - Pediatric pancreas MRI
KW - Pediatric pancreatitis
UR - https://www.scopus.com/pages/publications/105010528008
U2 - 10.1016/j.pan.2025.06.006
DO - 10.1016/j.pan.2025.06.006
M3 - Article
C2 - 40645819
AN - SCOPUS:105010528008
SN - 1424-3903
VL - 25
SP - 648
EP - 657
JO - Pancreatology
JF - Pancreatology
IS - 5
ER -